Home
Life Sciences

Sector: Life Sciences

Huawei, Intel among big firms selling patents in June-recorded transactions

Two deals could bring NPE risk but others stem from bankruptcies, buying and selling of business units and company product collaborations

Historic moment as UPC hands down two full decisions within 24 hours of each other

The Unified Patent Court has handed patentees a win and a loss in its first on-the-merits rulings

Pharma patent litigation highlights in Southeast Asia in early 2020s

Rouse highlights some of the most important pharma patent decisions issued by Southeast Asian courts in the past four years

Latest content

Bayer handed lifeline by UK Court of Appeal in battle with Xarelto generics

European courts have been divided in a hard-fought struggle over the best-selling drug

30 April 2024

GSK becomes latest mRNA patentee to enter covid IP wars, increasing pressure on Pfizer/BioNTech

Meanwhile BioNTech and Moderna face off in the UK, and another mRNA spat settles

29 April 2024

Alexion and Novartis/Genentech start UPC’s first ever biosimilar disputes

The patentees join Amgen as the only pharma companies yet to use the pan-European court

24 April 2024

Commercialisation of trade secrets remains elusive for many, but revenue streams are there to be had

At this week’s IAM Live: Trade Secret Strategy Europe event, only 11% of companies attending said they have an effective process in place to monetise trade secrets. IAM’s Maia Biermann reflects on why

20 April 2024

Brazil Supreme Court affirms term adjustment of non-pharmaceutical Monsanto patent

The decision hands an agribusiness asset case back to the trial court with potentially heavy financial ramifications for the IP owner and parent company Bayer

17 April 2024